Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)
Eton Pharmaceuticals (ETON) posted Other Non Operating Income of $1.2 million for Q4 2024, up 238.39% sequentially from -$831000.0 in Q4 2023, and up 238.39% YoY from $339847.1 in Q1 2024.
Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024) Analysis & Trends
Eton Pharmaceuticals has reported Other Non Operating Income for 4 years, with the latest figure at $1.2 million in Q4 2024.
- Quarterly Other Non Operating Income rose 238.39% year-over-year to $1.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.2 million (up 3809.68% YoY) and the FY2025 annual result came in at -$424000.0, down 136.87% from the prior year.
- Other Non Operating Income improved to $1.2 million in Q4 2024 per ETON's latest filing, from -$831000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.2 million in Q4 2024 and troughed at -$831000.0 in Q4 2023.
- A 4-year average of $459200.0 and a median of $800000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income plunged 202.34% in 2023, then soared 238.39% in 2024.
- Over 4 years, Other Non Operating Income stood at $365000.0 in 2021, then surged by 122.47% to $812000.0 in 2022, then slumped by 202.34% to -$831000.0 in 2023, then jumped by 238.39% to $1.2 million in 2024.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.2 million, -$831000.0, and $800000.0 for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | -831,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Jun 30, 2021 | 365,000.00 |